RxDoctor Payments Data

Richard Gurgel, MD

Otology & Neurotology · Salt Lake City, UTNPI 1710196290

Payments from drug & device makers

What this record shows

The money is spread across several categories — travel and lodging (57.0%), consulting fees and speaking fees — rather than concentrated in one kind of arrangement. 7 manufacturers reported payments, led by Cochlear Americas at 57.8% of the total. 2025 is the largest year on record at $40,302, more than ten times the $1,109 reported in 2019.

$62,341in general payments, 2019–2025

Across 124 payments — averaging $502.75 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Cochlear Americas$36K
  • Med-el Corporation$24K
  • Cochlear Ltd$1K
  • Iotamotion, Inc.$463
  • Stryker$380
  • Advanced Bionics, LLC$128
  • plus $93 from 1 others
$291,757in research payments, 2019–2025

Across 26 payments — averaging $11,221 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Cochlear Americas$247K
  • Advanced Bionics, LLC$44K

What the payments were for

  • Consulting fees$10,20016%
  • Speaking & faculty fees$8,81814%
  • Grants$1,0002%
  • Travel & lodging$35,51057%
  • Food & beverage$5,1048%
  • Education$1,7103%

General payments by program year

19
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Cochlear Americas62$36,048
Med-el Corporation46$24,121
Cochlear Ltd2$1,109
Iotamotion, Inc.3$463
Stryker8$380
Advanced Bionics, LLC2$128
Oticon Medical, LLC1$93

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

Too few otology & neurotology providers in Utahto place this figure against a meaningful peer group, so we don't.

Medicare billing

Part B allowed, 2024
$72,510
Medicare patients
114
Services billed
251

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Triamterene-HydrochlorothiazidTriamterene/Hydrochlorothiazid13$116

Paid to pharmacies, not to this prescriber.

Other otology & neurotology in Salt Lake City

Where these figures come from

Is this you, or does something look wrong? →